Evidence map›Paper›PMID 32707264›Full record

Trial reportInternational journal of radiation oncology, biology, physics2020

Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Short Course Results.

Ahmad Ameri, Nazanin Rahnama, Rama Bozorgmehr, Majid Mokhtari, Mohammad Farahbakhsh, Mahmood Nabavi, Simin Dokht Shoaei, Hossein Izadi, Amir Shahram Yousefi Kashi, Hadiseh Shabanpour Dehbaneh and 1 more

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in International journal of radiation oncology, biology, physics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2021
    Trial
  4. Trial
  5. Review
  6. Radiotherapy for non-cancer diseases: benefits and long-term risks.International journal of radiation biology · 2024
    Review
  7. Review
  8. Article
  9. Effects of COVID-19 on Arrhythmia.Journal of cardiovascular development and disease · 2022
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. COVID-19 and low-dose radiation therapy.Radiation medicine and protection · 2021
    Review
  17. In Regard to Shuryak et al.International journal of radiation oncology, biology, physics · 2021
    Article
  18. Article
  19. Effectiveness of low-dose radiation therapy to improve mortality of COVID-19.Journal of cancer research and clinical oncology · 2021
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ahmad AmeriDepartment of Clinical Oncology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Nazanin RahnamaDepartment of Clinical Oncology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: Yasamin98522@gmail.com.
Rama BozorgmehrClinical Research Development Unit, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Majid MokhtariLoghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammad FarahbakhshIDTM Research Center, Tehran, Iran.
Mahmood NabaviCenter for Communicable Disease Control, Ministry of Health and Medical Education, Tehran, Iran.
Simin Dokht ShoaeiClinical Research and Development Center, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hossein IzadiDepartment of Internal Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Amir Shahram Yousefi KashiCancer Research Center, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hadiseh Shabanpour DehbanehDepartment of Infectious Diseases, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Farzad Taghizadeh-HesaryDepartment of Clinical Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Shahid Beheshti University of Medical Sciences · IRImam Hossein Hospital · IRMinistry of Health and Medical Education · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe COVID-19 outbreak is affecting people worldwide. Many infected patients have respiratory involvement that may progress to acute respiratory distress syndrome. This pilot study aimed to evaluate the clinical efficacy of low-dose whole-lung radiation therapy in patients with COVID-19 pneumonia. METHODS AND MATERIALS: In this clinical trial, conducted in Iran, we enrolled patients with COVID-19 who were older than 60 years and hospitalized to receive supplementary oxygen for their documented pneumonia. Participants were treated with whole-lung irradiation in a single fraction of 0.5 Gy plus the national protocol for the management of COVID-19. Vital signs (including blood oxygenation and body temperature) and laboratory findings (interleukin-6 and C-reactive peptide) were recorded before and after irradiation.

resultsBetween May 21, 2020 and June 24, 2020, 5 patients received whole-lung irradiation. They were followed for 5 to 7 days to evaluate the response to treatment and toxicities. The clinical and paraclinical findings of 4 of the 5 patients (patient 4 worsened and died on day 3) improved on the first day of irradiation. Patient 3 opted out of the trial on the third day after irradiation. The mean time to discharge was 6 days for the other 3 patients. No acute radiation-induced toxicity was recorded.

conclusionsWith a response rate of 80%, whole-lung irradiation in a single fraction of 0.5 Gy had encouraging results in oxygen-dependent patients with COVID-19 pneumonia.

Indexed as

SARS-CoV-2AgedAged, 80 and overCOVID-19FemaleHumansIranLungMaleMiddle AgedPilot ProjectsRadiotherapy DosageTreatment Outcome

Identifiers

PMID32707264
PMCPMC7373065
OpenAlexW3044105001

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.